ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Liquidia Corporation

Liquidia Corporation (LQDA)

12.42
-0.42
(-3.27%)
Closed May 25 4:00PM
12.25
-0.17
(-1.37%)
After Hours: 6:59PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
12.25
Bid
12.48
Ask
13.25
Volume
548,170
12.36 Day's Range 12.9465
5.71 52 Week Range 16.99
Market Cap
Previous Close
12.84
Open
12.85
Last Trade
13
@
13.49
Last Trade Time
Financial Volume
$ 6,885,763
VWAP
12.5614
Average Volume (3m)
820,806
Shares Outstanding
76,027,776
Dividend Yield
-
PE Ratio
-12.05
Earnings Per Share (EPS)
-1.03
Revenue
17.49M
Net Profit
-78.5M

About Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH). It conducts research, development, and... Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH). It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles designed to improve the safety, efficacy, and performance of a wide range of therapies. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. Show more

Sector
Surgical,med Instr,apparatus
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
2004
Liquidia Corporation is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker LQDA. The last closing price for Liquidia was $12.84. Over the last year, Liquidia shares have traded in a share price range of $ 5.71 to $ 16.99.

Liquidia currently has 76,027,776 shares outstanding. The market capitalization of Liquidia is $945.79 million. Liquidia has a price to earnings ratio (PE ratio) of -12.05.

LQDA Latest News

Liquidia Corporation Reports First Quarter 2024 Financial Results and Provides Corporate Update

MORRISVILLE, N.C., May 13, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) today reported financial results for the first quarter ended March 31, 2024. The company will host a...

Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) 2024 International Conference on Its Open-Label Safety Study of L606 (Liposomal Treprostinil) in Patients with PAH and PH-ILD

MORRISVILLE, N.C., May 10, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today the company will present data related to the investigational use of L606 (liposomal...

Liquidia Corporation to Present at BofA Securities Health Care Conference 2024

MORRISVILLE, N.C., May 07, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that Michael Kaseta, chief operating officer and chief financial officer, will provide an...

Liquidia Corporation to Report First Quarter 2024 Financial Results on May 14, 2024

MORRISVILLE, N.C., May 07, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that it will report its first quarter 2024 financial results on May 14, 2024. The company...

Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare Conference

MORRISVILLE, N.C., April 02, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) (Liquidia or the Company) announced today that Dr. Roger Jeffs, Chief Executive Officer, and Micheal...

Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA™ (treprostinil) inhalation powder

On March 28, Judge Andrews removed the injunction issued in the Original Hatch Waxman LitigationOn March 29, Judge Bates denied United Therapeutics’ motion for temporary restraining order and...

Liquidia Corporation Reports Full Year 2023 Financial Results and Provides Corporate Update

Preparing to launch YUTREPIA™ (treprostinil) inhalation powder upon final FDA approvalFederal Circuit rejected request by United Therapeutics for rehearing of earlier decision finding ‘793 Patent...

Liquidia Corporation to Report Full Year 2023 Financial Results on Wednesday, March 13, 2024

MORRISVILLE, N.C., March 06, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that it will report its full year 2023 financial results on Wednesday, March 13, 2024...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.47-3.6949685534612.7213.5612.3258585513.06233824CS
4-0.12-0.97008892481812.3713.5611.6562830512.68729876CS
12-1.92-13.549752999314.1716.9911.6582080614.07087125CS
265.5382.29166666676.7216.996.69103781812.41630011CS
523.6943.10747663558.5616.995.7177776910.72298589CS
1569.3315.2542372882.9516.992.257649857.22116659CS
2602.5826.68045501559.6716.992.256533146.25106198CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
LUCYInnovative Eyewear Inc
$ 0.983
(428.49%)
944.4M
AKANAkanda Corporation
$ 4.07
(70.29%)
39.11M
TKLFYoshitsu Company Ltd
$ 0.3496
(53.33%)
84.5M
ONMDOneMedNet Corporation
$ 2.251
(53.13%)
136.04M
MRUSMerus NV
$ 59.92
(35.97%)
6.91M
VSTMVerastem Inc
$ 4.0901
(-66.42%)
19.68M
TOIIWOncology Institute Inc
$ 0.0443
(-55.61%)
280.55k
SNSESensei Biotherapeutics Inc
$ 0.7912
(-45.43%)
1.41M
GNLXGenelux Corporation
$ 2.61
(-43.26%)
3.32M
AUVIApplied UV Inc
$ 0.32
(-33.33%)
5.18M
LUCYInnovative Eyewear Inc
$ 0.983
(428.49%)
944.4M
GWAVGreenwave Technology Solutions Inc
$ 0.0843
(-4.85%)
428.98M
NCPLNetcapital Inc
$ 0.20
(14.42%)
191.35M
HLTHCue Health Inc
$ 0.0931
(-1.27%)
160.21M
ONMDOneMedNet Corporation
$ 2.251
(53.13%)
136.04M

LQDA Discussion

View Posts
Monksdream Monksdream 2 months ago
LQDA 10Q due 3/13
👍️0
Monksdream Monksdream 5 months ago
LQDA another 52 week high
👍️0
OverDraught OverDraught 5 months ago
And a day later... another new 52 week high.
A couple of weeks ago, BofA securities raised their price target from $13 to $15. Looks like they will have to raise it again.
👍️0
Monksdream Monksdream 5 months ago
LQDA new 52 week high
👍️0
OverDraught OverDraught 5 months ago
Looks like a short squeeze for LQDA today. Nice Christmas present.
👍️0
XenaLives XenaLives 1 year ago
Historic short interest:

You can go to this link to check short interest in a stock:
http://nasdaqtrader.com/Trader.aspx?id=ShortInterest

Publication schedule is here:
http://nasdaqtrader.com/Trader.aspx?id=ShortIntPubSch

Settlement Date Short Interest Percent Change
Average Daily Share Volume Days to Cover

01/31/2023 2,658,953 (7.66) 444,904 5.98
01/13/2023 2,879,384 (5.27) 533,632 5.40
12/30/2022 3,039,697 24.71 554,219 5.48
12/15/2022 2,437,325 (16.04) 638,343 3.82
11/30/2022 2,902,877 13.83 336,342 8.63
11/15/2022 2,550,166 (25.51) 409,963 6.22
10/31/2022 3,423,367 6.15 628,188 5.45
10/14/2022 3,224,962 (6.66) 399,148 8.08
09/30/2022 3,455,141 (0.33) 792,391 4.36
09/15/2022 3,466,521 37.77 2,576,549 1.35
08/31/2022 2,516,217 22.45 2,786,398 1.00
08/15/2022 2,054,960 0.68 2,336,698 1.00
07/29/2022 2,041,040 12.23 4,815,096 1.00
07/15/2022 1,818,618 5.86 325,677 5.58
06/30/2022 1,717,938 47.18 1,419,433 1.21
06/15/2022 1,167,230 (24.85) 778,151 1.50
05/31/2022 1,553,242 44.23 1,668,452 1.00
05/13/2022 1,076,900 (3.07) 647,509 1.66
04/29/2022 1,110,986 (6.74) 696,201 1.60
04/14/2022 1,191,248 13.25 982,786 1.21
03/31/2022 1,051,863 6.83 495,412 2.12
03/15/2022 984,626 (1.68) 628,521 1.57
02/28/2022 1,001,417 (8.42) 445,508 2.25
02/15/2022 1,093,527 (5.45) 307,947 3.55
*** missing data
12/15/2021 606,877 5.02 323,008 1.88
11/30/2021 577,894 (19.12) 540,301 1.07
11/15/2021 714,517 (1.20) 1,426,508 1.00
10/29/2021 723,213 0.31 338,789 2.13
10/15/2021 720,950 5.56 282,621 2.55
09/30/2021 682,963 3.62 214,797 3.18
09/15/2021 659,095 (2.28) 136,645 4.82
08/31/2021 674,478 (2.96) 189,615 3.56
08/13/2021 695,023 (6.98) 247,833 2.80
07/30/2021 747,184 (4.13) 225,645 3.31
07/15/2021 779,363 (7.60) 255,395 3.05
06/30/2021 843,424 (44.22) 730,055 1.16
06/15/2021 1,511,961 (12.40) 342,332 4.42
05/28/2021 1,725,947 (7.06) 449,958 3.84
05/14/2021 1,856,983 2.13 374,906 4.95
04/30/2021 1,818,174 (16.06) 409,956 4.44
04/15/2021 2,166,018 8.01 463,251 4.68
03/31/2021 2,005,431 (1.31) 788,431 2.54
03/15/2021 2,032,094 62.85 993,009 2.05
02/26/2021 1,247,832 29.54 1,939,000 1.00
02/12/2021 963,284 (16.18) 1,590,564 1.00
01/29/2021 1,149,239 (3.56) 2,119,176 1.00
01/15/2021 1,191,622 (12.41) 493,619 2.41
12/31/2020 1,360,412 17.85 918,901 1.48
👍️0
subslover subslover 2 years ago
Liquidia (NASDAQ:LQDA) Coverage Initiated by Analysts at Bank of America
https://www.defenseworld.net/2022/05/26/liquidia-nasdaqlqda-coverage-initiated-by-analysts-at-bank-of-america.html
👍️0
subslover subslover 2 years ago
Robert A. Lippe Buys 29,628 Shares of Liquidia Co. (NASDAQ:LQDA) Stock
https://www.defenseworld.net/2022/05/26/robert-a-lippe-buys-29628-shares-of-liquidia-co-nasdaqlqda-stock.html
👍️0
XenaLives XenaLives 2 years ago
Historic short interest:

You can go to this link to check short interest in a stock:
http://nasdaqtrader.com/Trader.aspx?id=ShortInterest

Publication schedule is here:
http://nasdaqtrader.com/Trader.aspx?id=ShortIntPubSch

Settlement Date Short Interest Percent Change
Average Daily Share Volume Days to Cover

12/15/2021 606,877 5.02 323,008 1.88
11/30/2021 577,894 (19.12) 540,301 1.07
11/15/2021 714,517 (1.20) 1,426,508 1.00
10/29/2021 723,213 0.31 338,789 2.13
10/15/2021 720,950 5.56 282,621 2.55
09/30/2021 682,963 3.62 214,797 3.18
09/15/2021 659,095 (2.28) 136,645 4.82
08/31/2021 674,478 (2.96) 189,615 3.56
08/13/2021 695,023 (6.98) 247,833 2.80
07/30/2021 747,184 (4.13) 225,645 3.31
07/15/2021 779,363 (7.60) 255,395 3.05
06/30/2021 843,424 (44.22) 730,055 1.16
06/15/2021 1,511,961 (12.40) 342,332 4.42
05/28/2021 1,725,947 (7.06) 449,958 3.84
05/14/2021 1,856,983 2.13 374,906 4.95
04/30/2021 1,818,174 (16.06) 409,956 4.44
04/15/2021 2,166,018 8.01 463,251 4.68
03/31/2021 2,005,431 (1.31) 788,431 2.54
03/15/2021 2,032,094 62.85 993,009 2.05
02/26/2021 1,247,832 29.54 1,939,000 1.00
02/12/2021 963,284 (16.18) 1,590,564 1.00
01/29/2021 1,149,239 (3.56) 2,119,176 1.00
01/15/2021 1,191,622 (12.41) 493,619 2.41
12/31/2020 1,360,412 17.85 918,901 1.48


👍️0
crudeoil24 crudeoil24 3 years ago
Needham On Liquidia Price Target Raise: Positive On 'Tentative FDA Approval For The Treatment Of Pulmonary Arterial Hypertension' Given Yutrepia Meets All FDA Standards For Approval; Sees Co. 'In A Much Stronger Position' Ahead Of March 2022 Trial

LQDA
👍️0
CHRSS CHRSS 3 years ago
LQDA looking good!!!
👍️0
CHRSS CHRSS 3 years ago
Hey fingers. I too picked up a bunch of cheap shares at this price point. LQDA!!!
👍️0
infamous infamous 3 years ago
i seem to be the ONLY real poster here. I just have to say that this will be over 4.50 again soon. Glad this little interest right now whilst i buy all these cheap 2.70 to 2.89 shares. LQDA
👍️0
infamous infamous 3 years ago
yea nice website. great 2 year chart at the bottom of this channel. we might be good for 100 to 500% increases from here IMO. LQDA
👍️0
CHRSS CHRSS 3 years ago
Agreed and same. I was reading through the company’s website earlier today. Very impressive. LQDA!!!
👍️0
infamous infamous 3 years ago
yea very few posters here. im getting anything 8 can under 2.90! great nasdaq stock chart! LQDA
👍️0
CHRSS CHRSS 3 years ago
Hi fingers. I’m new to LQDA. Seems like we are at a great entry point. LQDA!!!
👍️0
infamous infamous 3 years ago
bought more at 2.89
👍️0
infamous infamous 3 years ago
im in with a starter at 2.91. will hold however long. they might recover? LQDA
👍️0
Microlytics Microlytics 3 years ago
I'm in 3.04
👍️0
elcheepo elcheepo 4 years ago
bought in today
👍️0
lukin4winners lukin4winners 4 years ago
This is current news today. Nov 13th stockholders meeting.

RESEARCH TRIANGLE PARK, N.C, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (NASDAQ: LQDA), a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel products using its proprietary PRINT® technology, today announced it has rescheduled its special meeting of stockholders, which was originally scheduled for October 21, 2020, to be held at 4:30 p.m., Eastern Time, on November 13, 2020. The special meeting will be a virtual meeting conducted solely online via live webcast and can be attended by visiting www.meetingcenter.io/287587626.

As previously announced, on October 16, 2020, the Company received an unsolicited offer to enter into a License Agreement for the Company’s LIQ861 product candidate (the “Alternative Proposal”). The Alternative Proposal was conditioned upon the Company terminating the Agreement and Plan of Merger, dated as of June 29, 2020, by and among the Company, RareGen, LLC, Liquidia Corporation, Gemini Merger Sub I, Inc., Gemini Merger Sub II, LLC, and PBM RG Holdings, LLC (the “Merger Agreement”). On November 1, 2020, the Company’s board of directors (the “Board of Directors”) has determined that the Alternative Proposal does not constitute a Superior Proposal and the Company subsequently informed the counterparty that it is terminating discussions with respect to such Alternative Proposal.

Accordingly, the Board of Directors has unanimously reaffirmed its recommendations that the Company’s stockholders vote “FOR” each proposal being submitted to a vote of the Company’s stockholders at the Special Meeting.
👍️0
lukin4winners lukin4winners 4 years ago
Not sure but there is NO bad news. The only news 11/2 today is to announce the investor conference call moved to Nov 13th.
👍️0
swanlinbar swanlinbar 4 years ago
Liquidia to Report Third Quarter 2020 Financial Results and Provide Corporate Update on November 6, 2020
4:15 pm ET October 30, 2020 (Globe Newswire) Print
👍️0
swanlinbar swanlinbar 4 years ago
LQDA why the big drop this AM? Bad news coming?
👍️0
crudeoil24 crudeoil24 4 years ago
"SUPERIOR PROPOSAL" > Jason Adair

Vice President, Corporate Development and Strategy

LQDA
👍️0
dinogreeves dinogreeves 4 years ago
Just half that is enough for me, the rest will be his-story.
👍️0
crudeoil24 crudeoil24 4 years ago
Just 22 months ago LQDA was over 25.00 > "Show me the money!" (offer).
👍️0
dinogreeves dinogreeves 4 years ago
We will soon find out how superior it is.
👍️0
crudeoil24 crudeoil24 4 years ago
Another run to $25.00+ > SUPERIOR OFFER!!!!!
👍️0
dinogreeves dinogreeves 4 years ago
and then we have news today that the offer is superior and that is why they postponed the shareholder meeting.
👍️0
crudeoil24 crudeoil24 4 years ago


Liquidia Technologies Inc. said it received an unsolicited offer for a license agreement for its LIQ861 product candidate.
👍️0
lemons789 lemons789 4 years ago
Any thoughts on the United Theraputics / MannKind collaboration for similar PAH dry powder inhaler?

Also, anyone know what caused the price decline from Feb 2019 to Jan 2020?
👍️0
ClayTrader ClayTrader 4 years ago
* * $LQDA Video Chart 12-26-2019 * *

Link to Video - click here to watch the technical chart video

👍️0
logsplitter logsplitter 4 years ago
Already in it. Beat him to it
👍️0
Earlofsandwich Earlofsandwich 4 years ago
clay is watching LQDA just may be a play of the day.
👍️0
ClayTrader ClayTrader 4 years ago
* * $LQDA Video Chart 12-24-2019 * *

Link to Video - click here to watch the technical chart video

👍️0
dragonxbreath dragonxbreath 6 years ago
Well I really regret not buying this
👍️0
RedFive RedFive 6 years ago
I rarely buy at IPO but I find that the significant backers and the positive clinical trials will make LQDA a good candidate for anyone interested in new pharma (neopharmacy?). As the article below also stipulates, the dilution is low and brings the attraction of this one up. I'm in to see what 2019 will bring.

https://seekingalpha.com/article/4196391-liquidia-ipo-phase-3-clinical-stage-interested-bill-gates-foundation
👍️0
dragonxbreath dragonxbreath 6 years ago
IPO went through today with expected pps. Although a rise early morning, it quickly fell from that. Interesting read on where the company is going in regards to their tech, however, revenues are negative as expected from a company in developmental phases.
👍️0

Your Recent History

Delayed Upgrade Clock